REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy

Aruna Sharma, Dafin F. Muresanu, Ranjana Patnaik, Preeti K. Menon, Z. Ryan Tian, Seaab Sahib, Ala Nozari, José Vicente Lafuente, Anca D. Buzoianu, Stephen D. Skaper, Igor Bryukhovetskiy, Igor Manzhulo, Lars Wiklund, Hari Shanker Sharma

Open source

DOI: 10.1016/bs.pbr.2021.06.003
Published: 2021
Container: Progress in Brain Research
Publisher: Elsevier
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/bs.pbr.2021.06.003,
  title = {REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy},
  author = {Aruna Sharma and Dafin F. Muresanu and Ranjana Patnaik and Preeti K. Menon and Z. Ryan Tian and Seaab Sahib and Ala Nozari and José Vicente Lafuente and Anca D. Buzoianu and Stephen D. Skaper and Igor Bryukhovetskiy and Igor Manzhulo and Lars Wiklund and Hari Shanker Sharma},
  year = {2021},
  journal = {Progress in Brain Research},
  doi = {10.1016/bs.pbr.2021.06.003},
  url = {https://doi.org/10.1016/bs.pbr.2021.06.003}
}

RIS

TY  - JOUR
TI  - REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy
AU  - Aruna Sharma
AU  - Dafin F. Muresanu
AU  - Ranjana Patnaik
AU  - Preeti K. Menon
AU  - Z. Ryan Tian
AU  - Seaab Sahib
AU  - Ala Nozari
AU  - José Vicente Lafuente
AU  - Anca D. Buzoianu
AU  - Stephen D. Skaper
AU  - Igor Bryukhovetskiy
AU  - Igor Manzhulo
AU  - Lars Wiklund
AU  - Hari Shanker Sharma
PY  - 2021
JO  - Progress in Brain Research
DO  - 10.1016/bs.pbr.2021.06.003
UR  - https://doi.org/10.1016/bs.pbr.2021.06.003
ER  -

APA

Sharma, A., Muresanu, D. F., Patnaik, R., Menon, P. K., Tian, Z. R., Sahib, S., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Skaper, S. D., Bryukhovetskiy, I., Manzhulo, I., Wiklund, L., & Sharma, H. S. (2021). REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Progress in Brain Research. https://doi.org/10.1016/bs.pbr.2021.06.003

Source records

crossref · retrieved 2026-09-26T22:06:40.936Z